Pluri Inc. (PLUR) Dividend History

Pluri Inc. (PLUR) is a healthcare technology company focused on developing and commercializing digital solutions for personalized medicine. The company leverages artificial intelligence and advanced analytics to enhance laboratory testing and diagnostics, aiming to improve patient outcomes through tailored treatment options.

Matam Advanced Technology Park, Haifa, L3, 3508409
Phone: 972-74-710-7171
Website: https://www.pluri-biotech.com

Dividend History

Pluri Inc. currently does not pay dividends

Company News

  • DarioHealth Corp. announced that its Chief Financial Officer, Zvi Ben-David, will retire on May 15, 2025. The company has appointed Chen Franco-Yehuda as the new CFO, Treasurer, and Secretary, effective upon Ben-David's retirement.

    Benzinga
    Featured Companies: BNRG DRIO
  • Pluri Inc., a biotechnology firm, is facing the possibility of being delisted from the Nasdaq Capital Market due to failing to meet the minimum stockholders' equity requirement. The company has submitted a compliance plan and has been granted an extension until November 2024 to regain compliance.

    Investing.com
  • HAIFA, Israel, June 18, 2024 (GLOBE NEWSWIRE) -- Leading biotechnology company Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), which transforms cells into solutions that promote global wellbeing and sustainability, today announced strategic investments in Pluri’s subsidiary, Ever After Foods Ltd. (“Ever After Foods”), which offers a cutting-edge technology platform to produce cultivated food with unmatched, cost-efficient scalability. Ever After Foods is Pluri’s majority-owned joint venture with Israeli food giant Tnuva Food-Tech Incubator (2019), L.P. (“Tnuva”), and has exclusive licensing rights to use Pluri’s technology and intellectual property to develop, manufacture and commercialize cultivated meat. The $10 million funding round will propel Ever After Foods’ cost-advantageous and scalable technology platform, positioning it as a leading technology enabler.

    GlobeNewswire Inc.
Page data last updated 07/23/2025 21:45:48 UTC